Feedback / Questions
CAL101 - Calluna Pharma
https://www.businesswire.com/news/home/20251031655764/en/Calluna-Pharma-Announces-U.S.-FDA-Orphan-Drug-Designation-Granted-to-CAL101-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis-IPF
Oct 31, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next